Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Clinical trial NCT04296214 · WITHDRAWN
Trial details
- NCT number
- NCT04296214
- Sponsor
- Grupo Cooperativo de Hemopatías Malignas
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.